Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Abbvie raises sales outlook of two new drugs to more than $17.5 billion in 2025
The company's previous sales outlook for Skyrizi and Rinvoq in 2025 was more than $15 billion
Sun Pharma launches Palbociclib, therapy for advanced breast cancer
Sun Pharma’s brand, Palentom, is the branded generic version of the innovator product
Merck to take legal action against unauthorised distributors of its COVID treatment in China
Merck added that Sinopharm is the only legally authorised distributor of Merck's COVID-19 anti-viral molnupiravir in China
Sen Sanders asks Moderna not to hike COVID vaccine price
Sanders said in his letter that raising prices would be particularly egregious after the US government provided around $1.7…
Eisai files for approval of Alzheimer’s drug in Europe
The drug, developed in partnership with Biogen, is an antibody that has been shown to remove sticky deposits of a protein called…
BioNTech buys InstaDeep
BioNTech is to pay 362 million pounds upfront, in a mix of cash and an unspecified number of BioNTech shares, and up to 200…
Maharashtra governor honours Cadila Pharma’s Raj Prakash Vyas with ‘Award of…
The award recognises Vyas’s exemplary contribution to the industry for the last 28 years by creating new business development and…
AstraZeneca to buy US-based CinCor Pharma in $1.8 billion deal
AstraZeneca said it will pay $26 per CinCor share in cash, a premium of nearly 121 per cent to the stock's closing price
COVID-19: Covovax to get approval as booster in 10-15 days: Adar Poonawalla
He said everyone was looking at India, not just in terms of healthcare, but because the country managed to take care of a huge and…
USFDA issues CRL for proposed biosimilar Insulin-R: Biocon
The US Food and Drug Administration (USFDA) issues a Complete Response Letter (CRL) to convey to a company that its initial review…